Bayesian Capital Management, LP Abb Vie Inc. Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $467,565 - $541,275	3,500 New	3,500 $521,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $543,918 - $688,213	-5,063 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $4.39 Million - $4.98 Million	-41,237 Reduced 89.06%	5,063 $546,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $4.87 Million - $5.43 Million	46,300 New	46,300 $5.22 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $6.74 Million - $9.1 Million	-83,700 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $6.19 Million - $7.26 Million	72,023 Added 616.79%	83,700 $7.33 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $185,626 - $248,395	-2,530 Reduced 17.81%	11,677 $1.15 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $444,598 - $674,066	-6,893 Reduced 32.67%	14,207 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.52 Million - $1.9 Million	21,100 New	21,100 $1.87 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $365,284 - $439,176	-5,800 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $381,060 - $487,084	5,800 New	5,800 $422,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $3.42 Million - $3.81 Million	-38,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.26 Million - $1.49 Million	14,000 Added 57.14%	38,500 $3.57 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $975,306 - $1.31 Million	10,600 Added 76.26%	24,500 $2.32 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $1.33 Million - $1.46 Million	-14,900 Reduced 51.74%	13,900 $1.34 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $2.01 Million - $2.57 Million	28,800	28,800 $2.56 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account